Filter
2579
Filtered Results: 2579
Text search:
Surveillance
and
Epidemiology
Featured
Recommendations
258
New Publications
601
Language
Document type
No document type
1261
Studies & Reports
491
Guidelines
438
Strategic & Response Plan
142
Manuals
128
Fact sheets
42
Situation Updates
39
Training Material
24
Resource Platforms
6
Infographics
6
Brochures
1
App
1
Countries / Regions
Global
127
India
81
Latin America and the Carribbean
69
Western and Central Europe
67
Liberia
62
Africa
58
Sierra Leone
49
Nigeria
47
Ethiopia
47
Kenya
45
South Africa
45
Nepal
41
Uganda
34
Bangladesh
33
Philippines
31
Eastern Europe
31
Zambia
31
Ukraine
29
Brazil
28
Malawi
26
Guinea
25
Asia
24
Tanzania
24
Rwanda
23
Ghana
22
South–East Asia Region
22
Russia
22
Mozambique
20
Congo, Democratic Republic of
20
Germany
19
Myanmar / Burma
17
Zimbabwe
16
Senegal
15
Haiti
15
Syria
14
Namibia
14
Middle East and North Africa
13
Indonesia
13
Cameroon
12
West and Central Africa
12
East and Southern Africa
12
Pakistan
12
Eastern Europe and Central Asia
11
Burkina Faso
10
Venezuela
10
Tajikistan
9
Western Pacific Region
9
Botswana
9
Colombia
8
Lesotho
8
Albania
8
Paraguay
8
USA
7
Cambodia
7
North America
7
Argentina
7
Yemen
7
Mali
7
Angola
7
South Sudan
7
Thailand
6
Afghanistan
6
Peru
6
Vietnam
6
Chile
5
Niger
5
Côte d’Ivoire / Ivory Coast
5
Moldova
5
Chad
5
Madagascar
5
North Macedonia
4
France
4
Bolivia
4
Lebanon
4
Ecuador
4
China
3
Iran
3
Jordan
3
Saudi Arabia
3
Tunisia
3
Spain
3
Sri Lanka
3
Sudan
3
Iraq
3
Somalia
3
Eswatini/ Swaziland
3
Mexico
2
El Salvador
2
Turkey
2
Benin
2
Gambia
2
Togo
2
Kazakhstan
2
Laos
2
Kyrgyzstan
2
Morocco
2
Qatar
2
Mauritania
2
Armenia
2
Belarus
2
Bosnia and Herzegovina
2
Egypt
2
Central African Republic
2
Honduras
2
Libya
2
Timor Leste/ East Timor
1
Estonia
1
Congo-Brazzaville
1
Uzbekistan
1
Burundi
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Portugal
1
Israel
1
Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Greece
1
Georgia
1
Bhutan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
846
Clinical Guidelines
248
Public Health
153
Key Resources
115
Women & Child Health
64
Pharmacy & Technologies
38
Capacity Building
23
Toolboxes
COVID-19
291
TB
252
HIV
214
Rapid Response
198
NTDs
166
AMR
156
Ebola & Marburg
112
Planetary Health
84
Mental Health
82
Malaria
61
NCDs
52
Zika
45
Cholera
38
Polio
35
Pharmacy
32
Global Health Education
32
Caregiver
26
Refugee
23
Conflict
23
Natural Hazards
20
Disability
16
Health Financing Toolbox
13
Specific Hazards
11
Social Ethics
1
Typhoon
1
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Le présent document est une mise à jour du document d’information scientifique publié le 29 mars 2020 intitulé Modes of transmission of virus causing COVID-19: implications for infection prevention and control (IPC) precaution recommendations et comprend les nouvelles don...
The aim of the meeting was to broaden the network’s initiatives. Preliminary work involved integrating laboratory testing for skin NTDs other than Buruli ulcer, such as cutaneous leishmaniasis, mycetoma, leprosy and yaws, while extending the network’s reach to encompass additional laboratories.
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis...
This guidance document is designed to ensure that the process of iteratively managing the health risks of climate change is integrated into the overall National Adaptation Planning (NAP) process, including through assessing risks; identifying, prioritizing, and implementing adaptation options; and m...
Lancet Glob Health 2022 Published Online May 24, 2022 https://doi.org/10.1016/S2214-109X(22)00185-1
Many commercial actors use a range of coordinated and sophisticated strategies to protect business interests— their corporate playbook—but many of these strategies come at the expense of public h...
Every year, nearly 250 million people move across borders temporarily or permanently for a job opportunity, studying, to flee a crisis back home, or for other reasons. Another 750 million move for similar reasons within the borders of their countries. With the understanding that human mobility affec...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars. Humans usually acquire
leptospirosis through dire...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
Since the last situation report on the multi-country outbreak of cholera was published on 1 June 2023 (covering data reported until 15 of May), no new country reported a cholera outbreak. In total, 24 countries have reported cases since the beginning of 2023. The WHO African Region remains the most ...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
Interim Version 24, February 2020
This checklist has been prepared with the aim of supporting hospital managers and emergency planners in achieving the above by defining and initiating actions needed to ensure a rapid response to the COVID-19 outbreak. The checklist is structured on eleven key co...
Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assessing, at field level, the yellow fever virus circulation in areas at risk, and is primarily intended fo...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
